A seminal study demonstrated a possible mechanism involving inhibition of endothelin-1 (ET-1) synthesis, a vasoactive peptide that is associated with the development of coronary atherosclerosis [8,9]. The gene discussed is EDN1; the disease is coronary atherosclerosis.